Matrine diatomic alcohol plastid temperature-sensitive gel and preparation method thereof

A temperature-sensitive gel and matrine technology, applied in liquid delivery, pharmaceutical formulations, aerosol delivery, etc., can solve the limitations of the clinical application of matrine alkaloid thermo-sensitive gel, short local action time, and patient Poor compliance and other problems, to achieve the effect of being conducive to industrial production and popularization, improving the therapeutic effect and prolonging the effect time

Inactive Publication Date: 2015-05-27
WUHAN UNIV OF TECH
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] When clinically used to treat gynecological diseases, matrine preparations are usually made into vaginal suppositories, effervescent tablets, films and gels. These traditional dosage forms have certain defects in actual use: suppositories are made of solid The form of administration has foreign body sensation, poor patient compliance, inconvenient use, and the problem of medication dead ends; although the effervescent tablet (patent CN1439370A) is uniformly administered, the local action time is short, and a large amount of water-soluble substrate discharge pollutes the clothes; membrane Matrine gel (patent CN1593408A) has slow-release characteristics, which can solve the problem of short drug action time, but there are dead ends and foreign body sensation, and the patient's compliance is poor during administration; matrine gel (patent CN1410060A) is New drugs approved by the State Food and Drug Administration in 2005
[0006] Poloxamer polymers are one of the most researched and used gel materials. The published patent: a heat-sensitive gel containing matrine alkaloids and its preparation method (Patent No.: CN1850076A ), the temperature-sensitive gel is administered in liquid form, which is convenient for medication and has good patient compliance. At the same time, the drug is in close contact with the mucous membrane of the administration site, which has obvious advantages compared with previous dosage forms. However, studies have shown that hypromellose Addition of the element has little delaying effect on gel dissolution and drug release
Therefore, the gel dissolves too fast, and the problem of drug loss with the gel solution limits the clinical application of the sophora alkaloid thermosensitive gel.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Matrine diatomic alcohol plastid temperature-sensitive gel and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] 1) Dissolve 0.25g of matrine in 53.65g of phosphate buffer (pH 4.5), keep a constant temperature of 37±1°C; slowly add lecithin low molecular weight alcohol solution under stirring (lecithin 1.5g, low molecular weight Alcohol 13.0g, ethanol: propylene glycol ratio of 1:1); under ice bath conditions, use a probe-type ultrasonic instrument to ultrasonically disperse for 90S, and filter with a 0.45μm filter membrane to obtain a whey-colored matrine glycol plastid suspension;

[0033] 2) Add 0.6g chitosan to matrine diol plastid suspension, store at low temperature (-4°C, 24h); then add 6g glycerol and 25g poloxamer (poloxamer 407: poloxamer Sham 188 (4:1), stir evenly and store at low temperature (-4°C, 24h), to obtain whey-colored matrine diol body temperature-sensitive gel.

[0034] 10g of each unit preparation is divided into disposable vaginal injectors, packaged, and injected into the vagina during use.

Embodiment 2

[0036] 1) Dissolve 1.0g of matrine in 41.2g of phosphate buffer (pH 4.0), keep a constant temperature of 37±1°C; slowly add lecithin low molecular weight alcohol solution under stirring (lecithin 1.0g, low molecular weight Alcohol 30.0g, ethanol: propylene glycol ratio of 2:1); under ice bath conditions, use a probe-type ultrasonic instrument to ultrasonically disperse for 90S, and filter with a 0.45μm filter membrane to obtain a whey-colored matrine glycol plastid suspension;

[0037] 2) Add 0.8g chitosan to matrine diol plastid suspension, store at low temperature (-10°C, 48h); then add 10g glycerol and 16g poloxamer (poloxamer 407: poloxamer Sharm 188 (3:1), stir evenly and store at low temperature (-4°C, 24h), to obtain whey-colored matrine diol body temperature-sensitive gel.

[0038] Each unit preparation is 4g, divided into disposable vaginal injectors, packaged, and injected into the vagina during use.

Embodiment 3

[0040] 1) Dissolve 0.25g of matrine in 55g of phosphate buffer (pH 3.5), keep a constant temperature of 37±1°C; slowly add lecithin low molecular alcohol solution under stirring (lecithin 0.25g, low molecular alcohol 18.5g, ethanol: propylene glycol ratio of 5:1); under ice bath conditions, use a probe-type ultrasonic instrument to ultrasonically disperse for 90S, and filter through a 0.45μm filter membrane to obtain a whey-colored matrine glycol plastosome suspension;

[0041]2) Add 1.0g chitosan to matrine diol plastid suspension, store at low temperature (-4°C, 24h); then add 5g glycerol and 20g poloxamer (poloxamer 407: poloxamer Sharm 188 (1:1), stir evenly and store at low temperature (-10°C, 48h), to obtain whey-colored matrine diol body temperature-sensitive gel.

[0042] 10g of each unit preparation is divided into disposable vaginal injectors, packaged, and injected into the vagina during use.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a matrine diatomic alcohol plastid temperature-sensitive gel and a preparation method thereof, and aims to overcome the defects of vaginal dosage forms in the prior art. By adopting the matrine diatomic alcohol plastid temperature-sensitive gel, the medicine can be conveniently used, a patient does not have foreign body sensation, a medicine storage is formed in a vagina at the same time, the acting time of the medicine is long, and the bioavailability of matrine can be fully improved. The matrine diatomic alcohol plastid temperature-sensitive gel is prepared from the following raw materials in percentage by weight: 0.25-1.5% of matrine, 0.25-1.5% of lecithin, 0.5-1% of chitosan, 13-30% of low-molecular-weight alcohol, 38-55% of a phosphate buffer solution, 15-35% of poloxamer and 5-10% of glycerol. The diatomic alcohol plastid using ethanol and propanediol as softening agents has high encapsulation efficiency and stability, is stable in structure, can increase the in vivo and in vitro pereutaoeous permeation to ensure that the medicine can be slowly released, thereby improving the therapeutical effect; in addition, the gel does not have obvious toxicity.

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical preparations, and in particular relates to a vaginal matrine diol body temperature-sensitive gel and a preparation method thereof. Background technique [0002] Gynecological diseases, such as trichomonal vaginitis, monilial vaginitis, chronic cervicitis, senile vaginitis, pelvic inflammatory disease, etc., are common gynecological diseases, which have the characteristics of recurrent attacks and lingering and difficult to heal. Gynecological diseases are often caused by trichomonas, mold and bacterial infections, and can also be caused by mixed infections. The treatment of these diseases is mainly based on topical vaginal application of antibiotics. Due to the wide incidence, long course and recurrent characteristics of this disease, as well as the decline in the sensitivity of pathogenic bacteria to drugs in recent years, many patients around the world have suffered a lot. Therefore, it ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/06A61K31/4375A61K47/10A61P15/02
Inventor 刘小平林如文
Owner WUHAN UNIV OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products